A study recently published in the journal Infection, Genetics and Evolution explored the attachment affinity of carbon nanotubes (CNTs) and carbon nano-fullerene towards numerous molecular targets of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Computational modeling of the 3D architectures of nano-fullerenes and CNTs was carried out, and molecule binding and molecular dynamic (MD) simulations were used to estimate the attachment affinity of the nanoparticles to the chosen target molecules. The research emphasizes the need of using carbon nanoparticles as a treatment for COVID-19.
COVID-19 Taking the World by Storm
The shocking COVID-19 epidemic attributed to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), first detected in Wuhan, China, in December of 2019, has since expanded globally. A virulent pathogen, SARS-CoV-2 belongs to the ß-coronavirus family and is a positive-stranded RNA virus. The spike glycoproteins that appear on the envelope give these pathogens a crown-like appearance. Other proteins in the viral structure include membrane and envelope proteins, nucleocapsid protein, and RNA dependent on RNA polymerase as structural proteins.
Inadequacy of Current Treatments
At first, anti-viral medications including remdesivir, lopinavir, chloroquine, and hydroxychloroquine were recommended for COVID-19 infection therapy. Recent assessments, however, proved the ineffectiveness of chloroquine and hydroxychloroquine when combatting SARS-CoV-2. Several drugs are in the early phases of clinical development.
Novel variants of the virus have been discovered in various regions across the globe, with these mutations exhibiting enhanced transmission and pathogenicity, as well as reduced neutralization.
Vaccines are now available to treat COVID-19, although they have not yet reached populations in some countries. The variety of symptoms found in the patients, as well as asymptomatic transmission and vaccination resistance data, indicate that the creation of an alternative treatment answer is imminently needed.

The binding potential of carbon nanofullerene towards the prioritized targets of SARS-CoV-2 is predicted by molecular docking. The binding affinity and interactions of carbon nano fullerene towards (a) spike glycoprotein (−13.7 kcal/mol), (b) RNA dependent RNA polymerase (−12.9 kcal/mol), (c) main protease (−11.4 kcal/mol), (d) papain-like protease (−10.6 kcal/mol) and (d) RNA binding domain of nucleocapsid protein (−10.1 kcal/mol). Image Credit: Skariyachan, S. et al
Nanotechnology and Computational Biology
Modern developments in nanotechnology have revealed the possibility of using nanoparticles such as CNTs and nano-fullerenes to target various areas of SARS-CoV-2, blocking its pathogenic effects. Carbon nanotubes are being touted as potential therapeutic materials owing to excellent mechanical capabilities, structural soundness, and tunability of functional groups.
Nanomaterials may be used to create nano-based COVID-19 protective devices and disinfectants. Furthermore, nanoparticles could be employed to function as antigen carriers or serve as an adjuvant medication for use concurrently with the upcoming COVID-19 vaccines.
The team used computation-based virtual screening and MD simulations to determine the binding capability of carbon nanotubes and nano-fullerenes to numerous putative target areas of the virus. Carbon nano-fullerenes have a potential affinity for SARS-CoV-2 targets, and carbon nanotubes have demonstrated possible interactions that might limit the virus’s harmful mechanism.
Identifying Structural Properties of Recognized Targets
Spike glycoproteins are the principal target of antibodies and are important in stimulating entrance into cells through the transmembrane spike. The transmembrane spike is composed of two functional subunits that are in charge of attaching to receptors of host cells and fusing the membranes of the virus and cells.
Each virus may identify distinct places of attachment and entrance by connecting with specific areas of the receptors in the host cell unit, depending on the type of viral strain. The major constituent of the viral machinery is responsible for replication and transcription; the RNA-dependent RNA polymerase (RdRp) is required for the survival of these viruses. Treatments targeting this area would be an excellent strategy.
The primary protease is an enzyme that is also involved in viral replication and transcription. The major protease is required for the digestion of viral RNA-translated polyproteins. Inhibiting this enzyme may aid in the prevention of viral replication. As a result, these proteins were chosen in the study because they might be potential therapeutic targets for SARS-CoV-2 infection.

The MD simulation trajectories of RNA binding domain of the nucleocapsid protein and nano tube complex (a) RMSD: Protein RMSD (Å) on the y-axis and time on the x-axis (b) Protein RMSF (Å) on the y-axis and residues on the x-axis (c) Protein-ligand contacts over the simulation course, (d) histogram representing interaction fraction on the y-axis and residues on the x-axis (e) Ligand RMSF (Å) on the y-axis and atoms on the x-axis and (f) Major interactions that occur during MD simulation. Image Credit: Skariyachan, S. et al
Conclusions
It may initially seem unimpressive that the targets adopt this orientation only after adsorption on hydrophobic surfaces. However, there is potential for various orientations concerning the adsorption process on hydrophobic or charged areas. Therefore, understanding the interaction modeling of many orientations is critical.
The present research lays the groundwork for future laboratory tests and exploratory trials. Despite the nanoparticles’ apparent toxic nature, they might be employed as possible leads for blocking the coronavirus target areas. Research has shown the success of their use in target-specified treatments, drug transportation processes, cancer-related therapies, and other applications.
The MD simulation tests indicated that the priority entities and nanoparticles undergo dynamic interactions, which are steady and promising. When compared to carbon-fullerenes, nanotubes have the higher binding energy of the two carbon nanoparticles.
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]















